Eli Rapoport, MD,BS

NYU Grossman School of Medicine

Eli Rapoport, MD, is a first-year Urology resident at New York University Grossman School of Medicine. His research predominantly focuses on defining characteristics of optimal candidates for focal therapy for prostate cancer. Recent published works characterize short- and intermediate-term oncological and functional outcomes after cryoablation among men with intermediate-risk prostate cancer.

Disclosure information not submitted.

Presentation(s):

• MP73-10: Patient-Reported Treatment Related Regret (TRR) Following Primary Partial Gland Cryoablation (PPGCA):A Prospective Cohort Study of Men with Localized Prostate Cancer

  Monday, May 1, 2023
  7:00 AM – 9:00 AM CST

• MP73-14: Biopsy Assessment of Oncologic Control Three Years Following Primary Partial Gland Cryoablation (PPGCA)

  Monday, May 1, 2023
  7:00 AM – 9:00 AM CST